Congress is expected to push back health care and drug pricing reforms to 2020 with the new year just around the corner, according to a Fierce Healthcare report.
The House passed a bill last week to give Medicare the power to cut drug prices, according to the report, but the legislation is not expected to receive the Senate’s stamp of approval.
To read the full report on Fierce Healthcare, click here.
